Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25

Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25
复制标题

甘草甜素通过差异调节 IL-17 和 IL-25 的产生来缓解 Con A 诱导的肝炎

DOI:
10.1016/j.biopha.2018.12.025
复制
发表时间:
2018
影响因子:
7.5
通讯作者:
Min Fang
Min Fang
中科院分区:
医学2区
文献类型:
--
作者:
Yuanyue Zhang;Lingyun Li;Chang Qi;Shuyao Hua;Xiaoyuan Fei;Feili Gong;Min Fang

文献摘要

相似文献

甘草甜素是一种三萜类化合物,已被报道为一种抗炎药,用于治疗包括肝炎在内的各种炎症性疾病。然而,甘草酸抑制炎症的机制尚不清楚。在Con A诱导的小鼠肝炎模型上,我们发现给予甘草酸苷可以减轻ConA诱导的肝损伤,表现为炎症细胞因子干扰素-γ、IL-6和IL-17的产生减少,以及血清丙氨酸转氨酶(ALT)的减少。阻断IL-17可显著减轻Con A挑战引起的肝损伤。有趣的是,与单独注射ConA相比,注射甘草酸苷和ConA的小鼠,无论是在mRNA水平还是在蛋白水平上,内源性Alarmin炎症分子高迁移率族蛋白1(HMGB1)都显著降低。相反,在ConA挑战的情况下给予甘草酸苷可上调IL-25的产生。此外,IL-25升高可诱导保护性淋巴细胞亚群Gr-1+CD11b+(髓源性抑制细胞,MDSCs)比例增加,从而抑制免疫细胞的活化,有利于ConA刺激引起的不良免疫反应的解决。结果表明,甘草酸对Con A诱导的小鼠肝炎有保护作用。这种保护作用尤其与减少IL-17的产生和增强IL-25的表达有关。本研究可能为临床治疗急性肝炎提供一种新的策略。
Glycyrrhizin, a triterpenoid compound, has been reported to be an anti-inflammatory agent for the treatment of a variety of inflammatory diseases including hepatitis. However, the mechanism by which glycyrrhizin inhibits inflammation is unclear. Using a Con A-induced hepatitis model in mice, we found that administration of glycyrrhizin ameliorates Con A-induced liver injury, which manifests as reduction in the production of inflammatory cytokines IFN-γ, IL-6 and IL-17, as well as serum alanine aminotransferase (ALT). Blockade of IL-17 dramatically mitigates liver injury resulting from Con A challenge. Interestingly, at both the mRNA and protein levels, the endogenous alarmin inflammatory molecule high-mobility group box 1 (HMGB1) is significantly decreased in mice injected with glycyrrhizin combined with Con A compared to those injected with Con A alone. In contrast, the administration of glycyrrhizin with Con A challenge up-regulates the production of IL-25. Furthermore, an increase in the proportion of protective lymphocyte subset, Gr-1+CD11b+(Myeloid-Derived Suppressor Cell, MDSCs), could be induced by increased IL-25 to restrain immune cell activation and favor the resolution of detrimental immune reactions caused by Con A challenge. The results indicate that glycyrrhizin plays a protective role in Con A-induced hepatitis. This protective role is particularly associated with reducing the production of IL-17 and enhancing the expression of IL-25. The present study may provide a new strategy for the treatment of acute hepatitis in the clinical setting.